Literatur
- 1
Bower M, Palmieri C, Dhillon T.
AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral
therapy.
Curr Opin Infect Dis.
2006;
19
14-19
- 2
Sgadari C. et al .
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression
of Kaposi sarcoma.
Nat Med.
2002;
8
225-232
- 3
Crane H M. et al .
Fatal Kaposi’s sarcoma-associated immune reconstitution following HAART initiation.
Int J STD AIDS.
2005;
16
80-83
- 4
Stebbing J. et al .
The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi’s
sarcoma.
Ann Oncol.
2006;
17
503-506
- 5
Jabr F I.
Acquired immunodeficiency syndrome-related Kaposi’s sarcoma of the axilla and breast
after percutaneous intravenous catheter insertion.
Int J Dermatol.
2005;
44
611-612
- 6
Di Lorenzo G. et al .
Management of AIDS-related Kaposi’s sarcoma.
Lancet Oncol.
2007;
8
167-176
Dr. med. Frank Grünhage
Medizinische Klinik und Poliklinik I
Universitätsklinik Bonn
Sigmund-Freud-Straße 25
53105 Bonn
eMail: Frank.Gruenhage@ukb.uni-bonn.de
